Market Overview:
The Global Stargardt Disease Therapeutics Market, valued at USD 197.1 million in 2023, is anticipated to grow significantly, reaching approximately USD 1,385.6 million by 2031. This growth is expected to occur at a compound annual growth rate (CAGR) of 28.8% from 2024 to 2031. Stargardt disease, a genetic disorder that impairs the retina and results in the loss of central...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian